ConductScience.org, home

Paper50067

Homing of liposomes to target cells.

Gregoriadis G and 1 other. Biochem Biophys Res Commun, 1975. Cited by 250 papers, by iCite.

Cite this record

ConductScience Library. Homing of liposomes to target cells. Papers, record 50067. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/50067

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Homing of liposomes to target cells.
PubMed
Journal
Biochem Biophys Res Commun
PubMed
Year
1975
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
250
iCite
Relative citation ratio, by iCite
7.38
iCite
Revised in PubMed
2019-06-12
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gregoriadis GG
2Neerunjun EDE D

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BleomycinMajor topic
FibroblastsMajor topic
HeLa CellsMajor topic
LiposomesMajor topic
Receptors, DrugMajor topic
Animals
Binding Sites
Cells, Cultured
Clostridium perfringens
Humans
Immunoglobulin G
Male
Mice
Mice, Inbred AKR
Neuraminidase
Peptide Hydrolases
Protein Binding
Rabbits
Rats
Streptomyces griseus
alpha-Fetoproteins

Source PubMed

Download CSV of topics

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 250 citations.

PMIDTitleJournalYearIn PapersSource
40006643Navigating the Clinical Landscape of Liposomal Therapeutics in Cancer Treatment.Pharmaceutics2025https://conductscience.org/library/papers/40006643PubMed
39179112Enhancing RNA-lipid nanoparticle delivery: Organ- and cell-specificity and barcoding strategies.J Control Release2024https://conductscience.org/library/papers/39179112PubMed
36293340The Role of Cryoprotective Agents in Liposome Stabilization and Preservation.Int J Mol Sci2022https://conductscience.org/library/papers/36293340PubMed
30884782What Drives Innovation: The Canadian Touch on Liposomal Therapeutics.Pharmaceutics2019https://conductscience.org/library/papers/30884782PubMed
27231934Liposomes in Drug Delivery: How It All Happened.Pharmaceutics2016https://conductscience.org/library/papers/27231934PubMed
22358978Selective modulation with liposomes containing Der. P1 labelled with monoclonal antibodies.Cytotechnology1991https://conductscience.org/library/papers/22358978PubMed
22358682Mab labelled liposomes as selective vehicles for drugs in H.I.V. infected cells.Cytotechnology1993https://conductscience.org/library/papers/22358682PubMed
21327726Quantitative analysis of phospholipids using nanostructured laser desorption ionization targets.Lipids2011https://conductscience.org/library/papers/21327726PubMed
17614359Nanosystems for simultaneous imaging and drug delivery to T cells.AAPS J2007https://conductscience.org/library/papers/17614359PubMed
7001454Receptor-mediated endocytosis of antibody-opsonized liposomes by tumor cells.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/7001454PubMed
6952214
A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies.
Proc Natl Acad Sci U S A1982https://conductscience.org/library/papers/6952214PubMed
6933495Targeting of lipid vesicles: specificity of carbohydrate receptor analogues for leukocytes in mice.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6933495PubMed
6803776Interaction of antibody-bearing small unilamellar liposomes with target free antigen in vitro and in vivo. Some influencing factors.Biochem J1981https://conductscience.org/library/papers/6803776PubMed
6364035Immunoglobulins as targeting agents for liposome encapsulated drugs.Pharm Weekbl Sci1983https://conductscience.org/library/papers/6364035PubMed
6176223Interaction of antibody-bearing small unilamellar liposomes with antigen-coated cells. The effect of antibody and antigen concentration on the liposomal and cell surface respectively.Biochem J1981https://conductscience.org/library/papers/6176223PubMed
3334453Immunoconjugates: applications in targeted drug delivery for cancer therapy.Pharm Res1987https://conductscience.org/library/papers/3334453PubMed
3200855In vivo stability of ester- and ether-linked phospholipid-containing liposomes as measured by perturbed angular correlation spectroscopy.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/3200855PubMed
2953668Immunomodulation with liposomes: the immune response elicited by liposomes with entrapped dichloromethylene-diphosphonate and surface-associated antigen or hapten.Immunology1987https://conductscience.org/library/papers/2953668PubMed
2736208Enhanced in vivo activity of adriamycin incorporated into controlled release microspheres.Br J Cancer1989https://conductscience.org/library/papers/2736208PubMed
2511188Enhancement of both intracellular uptake and antitumor action of cisplatinum on human neuroblastoma cells by encapsulation in liposomes.Jpn J Cancer Res1989https://conductscience.org/library/papers/2511188PubMed

See all 29 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/50067

GET https://conductscience.org/api/papers/v1/50067/cited_by?page=2